Hirotsu N - Search Results

1

Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.

Hayden FG, Sugaya N, Hirotsu N, Lee N, de Jong MD, Hurt AC, Ishida T, Sekino H, Yamada K, Portsmouth S, Kawaguchi K, Shishido T, Arai M, Tsuchiya K, Uehara T, Watanabe A; Baloxavir Marboxil Investigators Group. Hayden FG, et al. Among authors: hirotsu n. N Engl J Med. 2018 Sep 6;379(10):913-923. doi: 10.1056/NEJMoa1716197. N Engl J Med. 2018. PMID: 30184455 Free article. Clinical Trial.

2

Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection.

Kohno S, Yen MY, Cheong HJ, Hirotsu N, Ishida T, Kadota J, Mizuguchi M, Kida H, Shimada J; S-021812 Clinical Study Group. Kohno S, et al. Among authors: hirotsu n. Antimicrob Agents Chemother. 2011 Nov;55(11):5267-76. doi: 10.1128/AAC.00360-11. Epub 2011 Aug 8. Antimicrob Agents Chemother. 2011. PMID: 21825298 Free PMC article. Clinical Trial.

3

Clinical and virologic effects of four neuraminidase inhibitors in influenza A virus-infected children (aged 4-12 years): an open-label, randomized study in Japan.

Hirotsu N, Saisho Y, Hasegawa T, Shishido T. Hirotsu N, et al. Expert Rev Anti Infect Ther. 2018 Feb;16(2):173-182. doi: 10.1080/14787210.2018.1421945. Epub 2017 Dec 29. Expert Rev Anti Infect Ther. 2018. PMID: 29284320 Clinical Trial.

4

The effect of neuraminidase inhibitors on household transmission in Japanese patients with influenza A and B infection: A prospective, observational study.

Hirotsu N, Saisho Y, Hasegawa T. Hirotsu N, et al. Influenza Other Respir Viruses. 2019 Mar;13(2):123-132. doi: 10.1111/irv.12590. Epub 2018 Dec 28. Influenza Other Respir Viruses. 2019. PMID: 29989680 Free PMC article.

5

Baloxavir marboxil in Japanese patients with seasonal influenza: Dose response and virus type/subtype outcomes from a randomized phase 2 study.

Watanabe A, Ishida T, Hirotsu N, Kawaguchi K, Ishibashi T, Shishido T, Sato C, Portsmouth S, Tsuchiya K, Uehara T. Watanabe A, et al. Among authors: hirotsu n. Antiviral Res. 2019 Mar;163:75-81. doi: 10.1016/j.antiviral.2019.01.012. Epub 2019 Jan 23. Antiviral Res. 2019. PMID: 30684563 Clinical Trial.

6

A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients.

Taieb V, Ikeoka H, Ma FF, Borkowska K, Aballéa S, Tone K, Hirotsu N. Taieb V, et al. Among authors: hirotsu n. Curr Med Res Opin. 2019 Aug;35(8):1355-1364. doi: 10.1080/03007995.2019.1584505. Epub 2019 Apr 1. Curr Med Res Opin. 2019. PMID: 30810054

7

Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.

Uehara T, Hayden FG, Kawaguchi K, Omoto S, Hurt AC, De Jong MD, Hirotsu N, Sugaya N, Lee N, Baba K, Shishido T, Tsuchiya K, Portsmouth S, Kida H. Uehara T, et al. Among authors: hirotsu n. J Infect Dis. 2020 Jan 14;221(3):346-355. doi: 10.1093/infdis/jiz244. J Infect Dis. 2020. PMID: 31309975 Clinical Trial.

8

Antibody dynamics in Japanese paediatric patients with influenza A infection treated with neuraminidase inhibitors in a randomised trial.

Hirotsu N, Saisho Y, Hasegawa T, Kitano M, Shishido T. Hirotsu N, et al. Sci Rep. 2019 Aug 15;9(1):11891. doi: 10.1038/s41598-019-47884-0. Sci Rep. 2019. PMID: 31417163 Free PMC article. Clinical Trial.

9

Baloxavir Marboxil in Japanese Pediatric Patients With Influenza: Safety and Clinical and Virologic Outcomes.

Hirotsu N, Sakaguchi H, Sato C, Ishibashi T, Baba K, Omoto S, Shishido T, Tsuchiya K, Hayden FG, Uehara T, Watanabe A. Hirotsu N, et al. Clin Infect Dis. 2020 Aug 14;71(4):971-981. doi: 10.1093/cid/ciz908. Clin Infect Dis. 2020. PMID: 31538644 Free PMC article.

10

Efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors in the treatment of influenza virus infection in high-risk and uncomplicated patients - a Bayesian network meta-analysis.

Taieb V, Ikeoka H, Wojciechowski P, Jablonska K, Aballea S, Hill M, Hirotsu N. Taieb V, et al. Among authors: hirotsu n. Curr Med Res Opin. 2021 Feb;37(2):225-244. doi: 10.1080/03007995.2020.1839400. Epub 2020 Nov 9. Curr Med Res Opin. 2021. PMID: 33079575

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page